New dawn for NeuroScientific with stem cell acquisition

NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech shows potential in autoimmune disease and transplant medicine.